510(k) · Radiology

Discovery MI Gen2

by GE Medical Systems, LLC.

Discovery MI Gen2 is an AI-enabled medical device from GE Medical Systems, LLC. that the U.S. FDA cleared through 510(k) K211846 on August 20, 2021. Its lead review panel is Radiology and its primary product code is KPS (System, Tomography, Computed, Emission).

See also FDA-cleared AI radiology devices in 2021, all FDA AI clearances in 2021, top radiology AI devices.

Key facts

Submission numberK211846
Pathway510(k)
Date of final decision
Company (FDA list)GE Medical Systems, LLC.
Lead review panelRadiology
Primary product codeKPS — System, Tomography, Computed, Emission
Applicant (openFDA)Ge Medical Systems, LLC
Applicant locationWaukesha, WI, US
Device classClass 2
Regulation number21 CFR 892.1200
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. Discovery MI Gen2 went through this pathway (K211846).

openFDA lists it as a Class 2 device under 21 CFR 892.1200. Class II devices are moderate risk and are subject to general and special controls.

Product code KPS covers 26 devices on the FDA AI list. By decision date, this device is #8 of 26 under that code. GE Medical Systems, LLC. has 24 AI-enabled devices on the list, and the Radiology panel accounts for 1,230 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code KPS)

More from GE Medical Systems, LLC.